Holen Sie sich die Stockscreener-App
1.67
4.57%
-0.08
Handel nachbörslich:
1.75
0.08
+4.79%
Schlusskurs vom Vortag:
$1.75
Offen:
$1.7
24-Stunden-Volumen:
94,773
Relative Volume:
0.40
Marktkapitalisierung:
$130.88M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.91%
1M Leistung:
-11.64%
6M Leistung:
+80.54%
1J Leistung:
+46.49%
1-Tages-Spanne:
$1.63
$1.74
1-Wochen-Bereich:
$1.63
$1.93
52-Wochen-Spanne:
$0.5506
$6.19
Citius Oncology Inc Stock (CTOR) Company Profile
Firmenname
Citius Oncology Inc
Sektor
Telefon
(908) 967-6677
Adresse
11 COMMERCE DRIVE, CRANFORD
Vergleichen Sie CTOR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CTOR
Citius Oncology Inc
|
1.67 | 146.15M | 0 | 0 | 0 | 0.00 |
|
ZTS
Zoetis Inc
|
144.35 | 63.86B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.42 | 42.46B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.38 | 41.28B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.52 | 23.49B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
438.66 | 19.18B | 3.08B | 1.24B | 1.07B | 25.61 |
Citius Oncology Inc Stock (CTOR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-23 | Hochstufung | Maxim Group | Hold → Buy |
| 2024-11-27 | Eingeleitet | Maxim Group | Buy |
Citius Oncology Inc Aktie (CTOR) Neueste Nachrichten
Using Bollinger Bands to evaluate Citius Oncology Inc.Analyst Downgrade & Low Drawdown Momentum Ideas - newser.com
News impact scoring models applied to Citius Oncology Inc.Bull Run & Technical Entry and Exit Alerts - newser.com
Citius Oncology Inc.’s volatility index tracking explainedJobs Report & Free Community Consensus Stock Picks - newser.com
Will Citius Oncology Inc. stock rally after Fed decisionsMarket Sentiment Summary & High Conviction Buy Zone Picks - newser.com
What the charts say about Citius Oncology Inc. todayTrade Risk Summary & Daily Technical Forecast Reports - newser.com
Will Citius Oncology Inc. stock deliver strong dividend growth2025 AllTime Highs & Verified Chart Pattern Trade Signals - newser.com
Why Citius Oncology Inc. stock is a value investor pickPortfolio Growth Summary & Weekly Breakout Watchlists - newser.com
How Citius Oncology Inc. stock benefits from strong dollar2025 Geopolitical Influence & Accurate Buy Signal Alerts - newser.com
What data driven models say about Citius Oncology Inc.’s futureJuly 2025 Earnings & Reliable Trade Execution Plans - newser.com
Real time social sentiment graph for Citius Oncology Inc.Insider Buying & Breakout Confirmation Trade Signals - newser.com
Is Citius Oncology Inc. stock attractive for long term wealth buildingWeekly Gains Report & Daily Oversold Bounce Ideas - newser.com
Regression analysis insights on Citius Oncology Inc. performance2025 AllTime Highs & Smart Allocation Stock Tips - newser.com
Building trade automation scripts for Citius Oncology Inc.Trade Volume Report & Weekly Setup with ROI Potential - newser.com
What high frequency data says about Citius Oncology Inc.Trade Entry Summary & Low Risk Entry Point Tips - newser.com
Predicting Citius Oncology Inc. trend using moving averages2025 Performance Recap & Reliable Volume Spike Trade Alerts - newser.com
Why retail investors favor Citius Oncology Inc. stock2025 Winners & Losers & Real-Time Volume Trigger Notifications - newser.com
Published on: 2025-10-29 00:05:52 - newser.com
How analysts rate Citius Oncology Inc. stock todayJuly 2025 Chart Watch & Weekly High Return Stock Opportunities - Fundação Cultural do Pará
Published on: 2025-10-28 05:08:21 - newser.com
Is Citius Oncology Inc. stock a buy on dipsM&A Rumor & Weekly High Momentum Picks - fcp.pa.gov.br
Finanzdaten der Citius Oncology Inc-Aktie (CTOR)
Es liegen keine Finanzdaten für Citius Oncology Inc (CTOR) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.35%
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):